The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation

Jia Ke,1,* Meng-Ting Li,1,* Ya-Jing Huo,1 Yan-Qiong Cheng,2 Shu-Fen Guo,1 Yang Wu,1 Lei Zhang,3 Jianpeng Ma,4 Ai-Jun Liu,2 Yan Han1 1Department of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,...

Full description

Bibliographic Details
Main Authors: Ke J, Li MT, Huo YJ, Cheng YQ, Guo SF, Wu Y, Zhang L, Ma J, Liu AJ, Han Y
Format: Article
Language:English
Published: Dove Medical Press 2021-08-01
Series:Drug Design, Development and Therapy
Subjects:
Online Access:https://www.dovepress.com/the-synergistic-effect-of-ginkgo-biloba-extract-50-and-aspirin-against-peer-reviewed-fulltext-article-DDDT
id doaj-eba222dd5b424283872f1bd53992341e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Ke J
Li MT
Huo YJ
Cheng YQ
Guo SF
Wu Y
Zhang L
Ma J
Liu AJ
Han Y
spellingShingle Ke J
Li MT
Huo YJ
Cheng YQ
Guo SF
Wu Y
Zhang L
Ma J
Liu AJ
Han Y
The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation
Drug Design, Development and Therapy
ginkgo biloba
aspirin
antiplatelet
synergistic effect
chinese herb
arachidonic acid
author_facet Ke J
Li MT
Huo YJ
Cheng YQ
Guo SF
Wu Y
Zhang L
Ma J
Liu AJ
Han Y
author_sort Ke J
title The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation
title_short The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation
title_full The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation
title_fullStr The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation
title_full_unstemmed The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation
title_sort synergistic effect of ginkgo biloba extract 50 and aspirin against platelet aggregation
publisher Dove Medical Press
series Drug Design, Development and Therapy
issn 1177-8881
publishDate 2021-08-01
description Jia Ke,1,* Meng-Ting Li,1,* Ya-Jing Huo,1 Yan-Qiong Cheng,2 Shu-Fen Guo,1 Yang Wu,1 Lei Zhang,3 Jianpeng Ma,4 Ai-Jun Liu,2 Yan Han1 1Department of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 2Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai, People’s Republic of China; 3Department of Vascular Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 4Multiscale Research Institute of Complex Systems, Fudan University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ai-Jun LiuDepartment of Pharmacology, School of Pharmacy, Second Military Medical University, 800 Xiangyin Road, Yangpu, Shanghai, 200433, People’s Republic of ChinaEmail mrliuaijun@163.comYan HanDepartment of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Hongkou, Shanghai, 200437, People’s Republic of ChinaTel +86 21 51322043Email hanyan.2006@aliyun.comPurpose: We aimed to investigate potential synergistic antiplatelet effects of Ginkgo biloba extract (GBE50) in combination with aspirin using in vitro models.Methods: Arachidonic acid (AA), platelet activating factor (PAF), adenosine 5ʹ-diphosphate (ADP) and collagen were used as inducers. The antiplatelet effects of GBE50, aspirin and 1:1 combination of GBE50 and aspirin were detected by microplate method using rabbit platelets. Synergy finder 2.0 was used to analyze the synergistic antiplatelet effect. The compounds in GBE50 were identified by UPLC-Q/TOF-MS analysis and the candidate compounds were screened by TCMSP database. The targets of candidate compounds and aspirin were obtained in TCMSP, CCGs, Swiss target prediction database and drugbank. Targets involving platelet aggregation were obtained from GenCLiP database. Compound-target network was constructed and GO and KEGG enrichment analyses were performed to identify the critical biological processes and signaling pathways. The levels of thromboxane B2 (TXB2), cyclic adenosine monophosphate (cAMP) and PAF receptor (PAFR) were detected by ELISA to determine the effects of GBE50, aspirin and their combination on these pathways.Results: GBE50 combined with aspirin inhibited platelet aggregation more effectively. The combination displayed synergistic antiplatelet effects in AA-induced platelet aggregation, and additive antiplatelet effects occurred in PAF, ADP and collagen induced platelet aggregation. Seven compounds were identified as candidate compounds in GBE50. Enrichment analyses revealed that GBE50 could interfere with platelet aggregation via cAMP pathway, AA metabolism and calcium signaling pathway, and aspirin could regulate platelet aggregation through AA metabolism and platelet activation. ELISA experiments showed that GBE50 combined with aspirin could increase cAMP levels in resting platelets, and decreased the levels of TXB2 and PAFR.Conclusion: Our study indicated that GBE50 combined with aspirin could enhance the antiplatelet effects. They exerted both synergistic and additive effects in restraining platelet aggregation. The study highlighted the potential application of GBE50 as a supplementary therapy to treat thrombosis-related diseases.Keywords: Ginkgo biloba, aspirin, antiplatelet, synergistic effect, Chinese herb, arachidonic acid
topic ginkgo biloba
aspirin
antiplatelet
synergistic effect
chinese herb
arachidonic acid
url https://www.dovepress.com/the-synergistic-effect-of-ginkgo-biloba-extract-50-and-aspirin-against-peer-reviewed-fulltext-article-DDDT
work_keys_str_mv AT kej thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT limt thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT huoyj thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT chengyq thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT guosf thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT wuy thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT zhangl thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT maj thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT liuaj thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT hany thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT kej synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT limt synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT huoyj synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT chengyq synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT guosf synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT wuy synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT zhangl synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT maj synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT liuaj synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
AT hany synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation
_version_ 1721206360577671168
spelling doaj-eba222dd5b424283872f1bd53992341e2021-08-15T20:13:46ZengDove Medical PressDrug Design, Development and Therapy1177-88812021-08-01Volume 153543356067902The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet AggregationKe JLi MTHuo YJCheng YQGuo SFWu YZhang LMa JLiu AJHan YJia Ke,1,* Meng-Ting Li,1,* Ya-Jing Huo,1 Yan-Qiong Cheng,2 Shu-Fen Guo,1 Yang Wu,1 Lei Zhang,3 Jianpeng Ma,4 Ai-Jun Liu,2 Yan Han1 1Department of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 2Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai, People’s Republic of China; 3Department of Vascular Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 4Multiscale Research Institute of Complex Systems, Fudan University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ai-Jun LiuDepartment of Pharmacology, School of Pharmacy, Second Military Medical University, 800 Xiangyin Road, Yangpu, Shanghai, 200433, People’s Republic of ChinaEmail mrliuaijun@163.comYan HanDepartment of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Hongkou, Shanghai, 200437, People’s Republic of ChinaTel +86 21 51322043Email hanyan.2006@aliyun.comPurpose: We aimed to investigate potential synergistic antiplatelet effects of Ginkgo biloba extract (GBE50) in combination with aspirin using in vitro models.Methods: Arachidonic acid (AA), platelet activating factor (PAF), adenosine 5ʹ-diphosphate (ADP) and collagen were used as inducers. The antiplatelet effects of GBE50, aspirin and 1:1 combination of GBE50 and aspirin were detected by microplate method using rabbit platelets. Synergy finder 2.0 was used to analyze the synergistic antiplatelet effect. The compounds in GBE50 were identified by UPLC-Q/TOF-MS analysis and the candidate compounds were screened by TCMSP database. The targets of candidate compounds and aspirin were obtained in TCMSP, CCGs, Swiss target prediction database and drugbank. Targets involving platelet aggregation were obtained from GenCLiP database. Compound-target network was constructed and GO and KEGG enrichment analyses were performed to identify the critical biological processes and signaling pathways. The levels of thromboxane B2 (TXB2), cyclic adenosine monophosphate (cAMP) and PAF receptor (PAFR) were detected by ELISA to determine the effects of GBE50, aspirin and their combination on these pathways.Results: GBE50 combined with aspirin inhibited platelet aggregation more effectively. The combination displayed synergistic antiplatelet effects in AA-induced platelet aggregation, and additive antiplatelet effects occurred in PAF, ADP and collagen induced platelet aggregation. Seven compounds were identified as candidate compounds in GBE50. Enrichment analyses revealed that GBE50 could interfere with platelet aggregation via cAMP pathway, AA metabolism and calcium signaling pathway, and aspirin could regulate platelet aggregation through AA metabolism and platelet activation. ELISA experiments showed that GBE50 combined with aspirin could increase cAMP levels in resting platelets, and decreased the levels of TXB2 and PAFR.Conclusion: Our study indicated that GBE50 combined with aspirin could enhance the antiplatelet effects. They exerted both synergistic and additive effects in restraining platelet aggregation. The study highlighted the potential application of GBE50 as a supplementary therapy to treat thrombosis-related diseases.Keywords: Ginkgo biloba, aspirin, antiplatelet, synergistic effect, Chinese herb, arachidonic acidhttps://www.dovepress.com/the-synergistic-effect-of-ginkgo-biloba-extract-50-and-aspirin-against-peer-reviewed-fulltext-article-DDDTginkgo bilobaaspirinantiplateletsynergistic effectchinese herbarachidonic acid